Company / Inventory
Acadia Pharmaceuticals Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$111.4M
FY2025
5-year range
$11.6M / $111.4M
FY2021-FY2025
Trend
+21.5%
vs FY2024
Sector context
#43 of 105
Health Care
What the data says
At $111M, Acadia Pharmaceuticals's inventory ranks #43 of 105 in the Health Care sector. Inventory has increased for 3 consecutive years, from $12M in FY2022 to $111M in FY2025.
Based on SEC 10-K filings.
$111M in FY2025 with a 5-year CAGR of +63.0%.
Improved from $40M to $111M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +112.8%
- 5-Year CAGR
- +63.0%
- 10-Year CAGR
- -
Sector benchmark
#43 of 105 in Health CareTop 41% of 105This company $111.4M Sector average $885.3M
▼
-87.4% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's inventory has grown for 3 consecutive years.
- 5-year CAGR of +63.0%, indicating consistent growth.
- In FY2025, inventory increased 21.5% year-over-year.
- Ranks #43 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.4M | +21.5% |
| FY2024 | $91.7M | +126.7% |
| FY2023 | $40.4M | +249.9% |
| FY2022 | $11.6M | -18.0% |
| FY2021 | $14.1M | +45.6% |
| FY2020 | $9.7M | +52.7% |
| FY2019 | $6.3M | +55.8% |
| FY2018 | $4.1M | -22.4% |
| FY2017 | $5.2M | +25.7% |
| FY2016 | $4.2M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026